Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 24 Completed 22 Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 3 CNS 3 Plasma cell 2 Endocrine 2 Thoracic 1 Sarcoma 1 Other solid neoplasm 1 NET 1 Myeloid 1 Lymphoid 1 Head & Neck 1 Genitourinary 1 Gastrointestinal 1

Conditions

Metastatic Urothelial Cancer 1

Interventions

zimberelimab 1 sacituzumab govitecan 1 pembrolizumab 1 enfortumab vedotin 1 avelumab 1 Gemcitabine 1 Cisplatin 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Has announcements × Genitourinary × Clear all

NCT03547973 2026-03-16

TROPHY U-01

Gilead Sciences

Phase 2 Recruiting

827 enrolled 1 FDA

Metastatic Urothelial Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡